Mayne Pharma Group (MAYNF) Revenue (TTM): 259.52M

Mayne Pharma Group Ltd. (MAYNF)

1.87 -0.18 (-8.78%) USD | OTCM | Oct 09, 16:00

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2008. Start Trial.

Date	Value
June 30, 2026	259.52M
December 31, 2025	262.69M
June 30, 2025	264.56M
December 31, 2024	272.77M
June 30, 2024	254.56M
December 31, 2023	178.30M
June 30, 2023	90.67M
December 31, 2022	199.13M
June 30, 2022	274.16M
December 31, 2021	258.09M
June 30, 2021	299.02M
December 31, 2020	301.83M
June 30, 2020	306.37M
December 31, 2019	332.59M
June 30, 2019	375.82M
December 31, 2018	420.00M
June 30, 2018	410.74M
December 31, 2017	399.03M
June 30, 2017	431.82M

Date	Value
December 31, 2016	324.90M
June 30, 2016	194.59M
December 31, 2015	155.95M
June 30, 2015	116.93M
December 31, 2014	119.96M
June 30, 2014	131.49M
December 31, 2013	121.62M
June 30, 2013	85.22M
December 31, 2012	53.96M
June 30, 2012	53.52M
December 31, 2011	49.54M
June 30, 2011	46.29M
December 31, 2010	47.10M
June 30, 2010	30.46M
December 31, 2009	7.720M
June 30, 2009	0.00
December 31, 2008	0.00
June 30, 2008	0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks